News

Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Verywell Health on MSN18h
Daily GLP-1 Pill Shows Promise for Diabetes and Weight Loss, Eli Lilly Says
A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
Lilly's oral diabetes pill shows potential for blood sugar control and weight loss in global trial
The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...
Verywell Health on MSN9d
Foods to Eat and Avoid While on Semaglutide for Optimal Results
Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...
Experimental Eli Lilly weight loss drug proves promising for type 2 diabetics
People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...
First GLP-1 pill for weight loss, diabetes shows success in late-phase trial
Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...
Daily GLP-1 pill effective for diabetes and obesity, Eli Lilly says
A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...
New protein discovery replaces insulin for diabetics
In the search for better ways to treat diabetes, researchers at the University of Geneva have uncovered a promising new ...
Diabetes.co.uk9d
Growing array of treatment options now available for type 2 diabetes
Healthcare professionals should consider all emerging therapy options when treating type 2 diabetes, researchers have said. This comes after experts at the University of Virginia Health System have ...